Penbrook Management LLC Acquires 84,875 Shares of Aehr Test Systems $AEHR

Penbrook Management LLC lifted its position in Aehr Test Systems (NASDAQ:AEHR) by 205.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,250 shares of the semiconductor company’s stock after acquiring an additional 84,875 shares during the period. Aehr Test Systems makes up approximately 1.2% of Penbrook Management LLC’s holdings, making the stock its 17th biggest holding. Penbrook Management LLC’s holdings in Aehr Test Systems were worth $1,632,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of AEHR. Quantbot Technologies LP acquired a new stake in shares of Aehr Test Systems in the 1st quarter valued at approximately $31,000. GAMMA Investing LLC raised its position in shares of Aehr Test Systems by 1,753.1% in the 1st quarter. GAMMA Investing LLC now owns 7,079 shares of the semiconductor company’s stock valued at $52,000 after acquiring an additional 6,697 shares during the period. CWM LLC raised its position in shares of Aehr Test Systems by 15.1% in the 2nd quarter. CWM LLC now owns 6,062 shares of the semiconductor company’s stock valued at $78,000 after acquiring an additional 793 shares during the period. American Century Companies Inc. acquired a new stake in shares of Aehr Test Systems in the 1st quarter valued at approximately $86,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Aehr Test Systems by 8.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock valued at $126,000 after acquiring an additional 1,344 shares during the period. 69.69% of the stock is currently owned by institutional investors and hedge funds.

Aehr Test Systems Trading Up 8.6%

NASDAQ:AEHR opened at $25.52 on Tuesday. Aehr Test Systems has a 1-year low of $6.27 and a 1-year high of $34.35. The firm has a fifty day simple moving average of $25.26 and a 200 day simple moving average of $16.24. The stock has a market capitalization of $765.86 million, a PE ratio of -116.00 and a beta of 2.47.

Aehr Test Systems (NASDAQ:AEHR) last released its earnings results on Monday, October 6th. The semiconductor company reported $0.01 earnings per share for the quarter, meeting the consensus estimate of $0.01. Aehr Test Systems had a negative net margin of 11.71% and a negative return on equity of 2.41%. The business had revenue of $11.00 million during the quarter, compared to analysts’ expectations of $13.69 million. During the same period last year, the business earned $0.07 earnings per share. On average, equities analysts predict that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on AEHR shares. Craig Hallum downgraded shares of Aehr Test Systems from a “buy” rating to a “hold” rating and set a $24.00 price target on the stock. in a research report on Tuesday, October 7th. Zacks Research downgraded shares of Aehr Test Systems from a “hold” rating to a “strong sell” rating in a report on Thursday, October 9th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Aehr Test Systems in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell” and a consensus price target of $24.00.

Insiders Place Their Bets

In other news, Director Laura Oliphant sold 5,000 shares of Aehr Test Systems stock in a transaction on Friday, July 25th. The stock was sold at an average price of $21.50, for a total transaction of $107,500.00. Following the completion of the sale, the director owned 7,665 shares of the company’s stock, valued at approximately $164,797.50. This trade represents a 39.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Fariba Danesh sold 9,000 shares of Aehr Test Systems stock in a transaction on Thursday, October 9th. The stock was sold at an average price of $24.79, for a total value of $223,110.00. Following the sale, the director directly owned 16,643 shares of the company’s stock, valued at $412,579.97. This represents a 35.10% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,000 shares of company stock valued at $687,550 over the last ninety days. 6.80% of the stock is currently owned by company insiders.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.